Reacción a "Many of the mouse models used in laboratories show inconsistencies between their names and their genetic makeup, according to an analysis"

Is the article of good quality?

“The article is solid, extremely timely, and has significant practical implications. Biomedical research has always taken it for granted that laboratory mice are genetically what the label says they are. However, this study reveals, for the first time, that in many cases the animal’s actual genetic background differs completely from the information provided by the source laboratory. This affects not only the animal’s response to a disease or a drug, but also the conclusions of a study.

The publication is not radically innovative, but it quantifies a problem that the scientific community has suspected for decades. Its acceptance in one of the world’s most important scientific journals underscores that the problem is not the animal model itself, but the lack of rigor in its use. It is a message directed not only at the scientific community, but also at institutions, at a time when political pressure to reduce the use of laboratory animals is growing, especially in the United States.”

How does this fit with previously known evidence, and what implications might it have?

“A mouse’s genetic background is not a minor detail; in fact, it is probably the most important experimental variable and, at the same time, the least controlled. Numerous studies have shown that the same genetic mutation can produce radically different phenotypes depending on the animal’s genetic background. In other words, when two laboratories use ‘the same strain’ but with different genetic backgrounds, the results can be inconsistent without any apparent explanation.

This does not merely mean that the mice have genetic errors, but it raises the question of how many published studies might be affected by this problem and how much time and money has been wasted as a result. This research suggests that part of the answer may lie in something as basic as not knowing exactly which mouse is being used.

On the other hand, the article offers a solution that has already been implemented: a genetic quality control system designed to be interpretable even by non-experts. This is MiniMUGA, a commercial product already available, with public reference data and documentation detailed enough to allow for its reproduction by third parties.”

Are there any significant limitations to consider?

“Among the study’s main limitations is that the analysis of mouse strains is based on a U.S. bank, so we do not know if the problem is just as common or even more severe in other countries. Furthermore, the article does not discuss the economic cost of creating a ‘genetic ID’ for each mouse nor does it address the question of whether all laboratories worldwide could afford that additional expense. In fact, the MiniMUGA system is currently available only for strains from suppliers in the United States and Europe, which could limit its global implementation.

Finally, although the article demonstrates the existence of genetic inconsistencies in mice, the direct link between these and experimental errors is implied but not objectively proven. It is also unknown whether the rates of inconsistency would be comparable in strains maintained internally in academic laboratories, which could yield better or worse results depending on the rigor of each group.”